FY2025 · period end Dec '25 · from the 10-K filed Feb 24, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $13.95B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000920148-26-000157 | Jul 8, 2026 | Jul 10, 2026 | Jul 10, 2026 07:31 UTC | EDGAR |
| 8-K | 0000920148-26-000150 | Jun 30, 2026 | Jun 30, 2026 | Jun 30, 2026 20:20 UTC | EDGAR |
| 8-K | 0000920148-26-000147 | May 27, 2026 | May 27, 2026 | May 27, 2026 12:04 UTC | EDGAR |
| 8-K | 0000920148-26-000143 | May 21, 2026 | May 26, 2026 | May 26, 2026 20:01 UTC | EDGAR |
| 10-Q | 0000920148-26-000139 | Mar 31, 2026 | May 4, 2026 | May 4, 2026 18:10 UTC | EDGAR |
| 8-K | 0000920148-26-000135 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 10:57 UTC | EDGAR |
| 8-K | 0000920148-26-000131 | Apr 8, 2026 | Apr 9, 2026 | Apr 9, 2026 10:54 UTC | EDGAR |
| 8-K | 0000920148-26-000128 | Mar 31, 2026 | Mar 31, 2026 | Mar 31, 2026 20:21 UTC | EDGAR |
Direct links to SEC EDGAR. LH has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Income (Loss) Attributable to Parent·Q1 2014
Major restatementwas$113.1M
Revised up in a 10-K. Any P/E built on the original was 77.9% too high.
Operating Income (Loss)·Q1 2014
Major restatementwas$203.3M
Revised up in a 10-K.
Net Income (Loss) Available to Common Stockholders, Diluted·Q1 2015
Major restatementwas$700K
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q1 2015
Major restatementwas$700K
Revised up in a 10-K. Any P/E built on the original was 76.7% too high.
Gross Profit·Q1 2014
Major restatementwas$516.8M
Revised up in a 10-K.
Revenue, Net (Deprecated 2018-01-31)·Q1 2014
Major restatementwas$1.4B
Revised up in a 10-K. Any P/S built on the original was 76.2% too high.
LH is not the only one.
See every restatement we've found across the market — or get an alert the next time LH revises a number.
Restatements are detected by comparing every vintage of a fact across all of LABCORP HOLDINGS INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows LH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling LABCORP HOLDINGS INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on LH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on LH and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $12.16B |
| $11.86B |
| $13.14B |
| Gross Profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B |
|---|
| Operating Income | $1.38B | $1.09B | $0.73B | $1.44B | $3.05B |
|---|
| Net Income | $0.88B | $0.75B | $0.42B | $1.28B | $2.38B |
|---|
| EPS (Diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $18.39B | $18.38B | $16.73B | $20.16B | $20.39B |
| Total Liabilities | $9.76B | $10.31B | $8.83B | $10.04B | $10.09B |
| Stockholders' Equity | $8.62B | $8.05B | $7.88B | $10.10B | $10.27B |
| Cash & Equivalents | $0.53B | $1.52B | $0.54B | $0.43B | $1.47B |
| Total Debt | — | $3.32B | $1.98B | $1.97B | $2.66B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.64B | $1.59B | $1.33B | $1.96B | $3.11B |
| Capital Expenditures | $0.43B | $0.49B | $0.45B | $0.43B | $0.42B |
| Free Cash Flow | $1.21B | $1.10B | $0.87B | $1.53B | $2.69B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 28.8% | 27.9% | 27.7% | 31.3% | 38.0% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% |
| Net Margin | 0.1% | 0.1% | 0.0% | 0.1% | 0.2% |
| Return on Equity | 10.5% | 9.4% | 4.7% | 12.6% | 24.1% |
| Return on Assets | 4.8% | 4.3% | 2.3% | 6.3% | 11.8% |
| Debt / Equity | 0.65× | 0.41× | 0.25× | 0.20× | 0.26× |
